Results 31 to 40 of about 15,799 (243)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Meningococcal disease is highly transmissible, life-threatening and leaves significant sequelae in survivors. Every year, India, which has a plethora of risk factors for meningococcal disease, reports around 3000 endemic cases.
Anand P. Dubey   +4 more
doaj   +1 more source

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia [PDF]

open access: yesNew England Journal of Medicine, 2020
BACKGROUND: The meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain.
Martin C. J. Maiden   +17 more
openaire   +5 more sources

Meningococcal Vaccines of New Generations – the First 20 Years of Use

open access: yesЭпидемиология и вакцинопрофилактика, 2021
Relevance. Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis. Therefore, there is a great scientific and practical interest in the existing and developed menicococcal vaccines.Aims the review is to ...
N. N. Kostyukova, V. A. Bekhalo
doaj   +1 more source

VaccineLies: A Natural Language Resource for Learning to Recognize Misinformation about the COVID-19 and HPV Vaccines [PDF]

open access: yesarXiv, 2022
Billions of COVID-19 vaccines have been administered, but many remain hesitant. Misinformation about the COVID-19 vaccines and other vaccines, propagating on social media, is believed to drive hesitancy towards vaccination. The ability to automatically recognize misinformation targeting vaccines on Twitter depends on the availability of data resources.
arxiv  

Recommendations of the Polish Paediatric Society, the Polish Society of Vaccinology, and the Polish Society of Family Medicine on meningococcal vaccinations in children and adults in Poland

open access: yesPediatria Polska, 2022
Invasive meningococcal disease is a dangerous bacterial infection that often leads to death or permanent disability. Immunization is the best strategy to protect individuals against invasive infections caused by Neisseria meningitidis.
Ernest Kuchar   +10 more
doaj   +1 more source

Preventing invasive meningococcal disease in early infancy

open access: yesHuman Vaccines & Immunotherapeutics, 2022
This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa   +3 more
doaj   +1 more source

The Impact of Vaccination Behavior on Disease Spreading Based on Complex Networks [PDF]

open access: yesarXiv, 2021
Vaccination is an effective way to prevent and control the occurrence and epidemic of infectious diseases. However, many factors influence whether the residents decide to get vaccinated or not, such as the efficacy and side effects while individuals hope to obtain immunity through vaccination.
arxiv  

The important lessons lurking in the history of meningococcal epidemiology

open access: yesExpert Review of Vaccines
Introduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use during the ...
Ray Borrow, Jamie Findlow
doaj   +1 more source

Current safety issues with quadrivalent meningococcal conjugate vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source

COVID-19 Vaccine Hesitancy and Information Diffusion: An Agent-based Modeling Approach [PDF]

open access: yesarXiv, 2021
Despite the unprecedented success in the rapid development of several effective vaccines against the Cov-SARS-2, global vaccination rollout efforts suffer from vaccine distribution inequality and vaccine acceptance, leading to insufficient public immunity provided by the vaccine products.
arxiv  

Home - About - Disclaimer - Privacy